[1] Stoop JN, van der Molen RG, Baan CC.et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. HEPATOLOGY,2005,41:771-778.
[2] Xu D, Fu J, Jin L.et al.Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol, 2006,177:739-747.
[3] Hyodo N, Nakamura I, Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol, 2004,135:462-466.
[4] Peng G, Li S, Wu W,et al. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology, 2008,123:57-65.
[5] Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther, 1998,3:13-24.
[6] Meyer zum Büschenfelde KH. Immunopathology of chronic liver diseases. Verh Dtsch Ges Pathol, 1995,79:186-197.
[7] Huang CF, Lin SS, Ho YC.et al. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol, 2006,3:97-106.
[8] Morelli G, Perrella A, Sbreglia C,et al. Antiviral therapy in acute viral hepatitis B: why and when. Infect Agent Cancer, 2009,16:2.
[9] Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4_CD25high regulatory cells in human peripheral blood. J Immunol, 2001,167:1245-1253.
[10] Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science, 2003,299:1057-1061.
[11] Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4+CD25+regulatory T lymphocytes in hepatitis C virus infection. HEPATOLOGY, 2004,40:1062-1071.
[12] Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol, 2003,3:51-62.
[13] Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol, 2003,39:595-605.
[14] Lau GK, Suri D, Liang R, et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology,2002,122:614-624.
[15] Rehermann, B., and M. Nascimbeni. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2008,5: 215-229.
[16] Belkaid, Y, and B. T. Rouse. Natural regulatory T cells in infectious disease. Nat Immunol, 2009,6: 353-360.
[17] Longhi, M. S., Y. Ma, et al. Impairment of CD4_CD25_ regulatory T-cells in autoimmune liver disease. J. Hepatol, 2009,41: 31-37.
[18] Baecher-Allan, C, J. A. Brown, J. Freeman, and D. A. Hafler. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol, 2010,167:1245-1253. |
